Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited is Japan’s largest pharmaceutical company and one of the world’s leading research-driven biopharmaceutical organizations. Established in 1781 in Osaka, Japan, Takeda has evolved from a traditional medicine business into a global healthcare company with operations in more than 80 countries and regions. Headquartered in Tokyo, the company focuses on developing innovative medicines for oncology, gastroenterology, neuroscience, rare diseases, plasma-derived therapies, and vaccines.

Takeda combines advanced biotechnology, genomics, artificial intelligence, digital health technologies, and precision medicine to accelerate scientific discovery and deliver innovative treatments for patients with complex diseases. The company has strengthened its global position through strategic acquisitions, including the integration of Shire, significantly expanding its rare disease and plasma-derived therapy portfolio.

Takeda operates a worldwide network of research centers, manufacturing facilities, and commercial operations while maintaining rigorous international quality standards and regulatory compliance. The company collaborates with academic institutions, biotechnology companies, governments, and healthcare providers to advance medical research and improve patient outcomes. Sustainability, ethical business practices, patient-centric innovation, and long-term scientific investment remain central to Takeda’s corporate philosophy. With more than two centuries of pharmaceutical heritage, Takeda continues to contribute to global healthcare through innovative medicines that improve millions of lives around the world.